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1. INTRODUCTION
We recently encountered an older patient with severe hypertensive 
re tinopathy on her right eye who had been normotensive all her 
life as documented not only by serial office blood pressure mea-
surements but also with ambulatory blood pressure monitoring. 
Unappreciated hypertension, is said to be masked from view and 
therefore, unappreciated and untreated. Masked hypertension is 
currently defined as existent hypertension even though office indi-
rect brachial artery measurements with syphygmomanometry are 
normal. The condition can be detected by 24-h Ambulatory Blood 
Pressure Monitoring (ABPM) or with home blood pressure mea-
surements. However, our concern here is not the blood pressure 
at the brachial artery. The hand is seldom the site of target-organ 
damage. Our issue is what happens centrally. Can the central aortic 
hypertension be masked when only brachial artery measurements 
are considered? This is obviously the case with our patient.
Augmentation designates the added systolic pressure contributed by 
the reflected pulse wave in stiff arteries with increasing age. As a result, 
the central aortic pressure progressively increases and is subsequently 
higher than the peripheral pressure at the brachial artery. The stiffer 
the vessels and the shorter the aorta as in short patients, the faster the 
pulse-wave velocity and the reflected pulse-wave, and the greater is 
the augmentation effect on systolic central aortic blood pressure.
2. THE CASE
A 78 year-old woman (159 cm, BMI 23 kg/m2) had previously enjoyed 
life-long good health. Her office blood pressure  measurements had 
invariably been normal. She had never required antihypertensive 
medication. ABPM had recently been performed that revealed a day 
time mean blood pressure of 137/75 mmHg and night time mean 
of 129/69 mmHg. Echocardiography had even been performed that 
showed normal dimensions of the left ventricle with some evidence 
of diastolic dysfunction.
The patient consulted an ophthalmologist because of difficulties 
in reading small texts. Her ophthalmologist detected changes 
in her retinal vessels funduscopically that were consistent with 
hypertension, an unexplained right-sided visual-field defect, and 
early cataract formation in the left eye. He referred her to spe-
cial ophthalmological circulatory laboratory for a more detailed 
evaluation. Objective findings were a visual acuity of 20/20 right 
eye and 10/20 left eye. The intraocular pressure was estimated 
at 21 mmHg in both eyes. The visual field map of right eye 
revealed an enlarged blind spot and arcuate scotomas within 30° 
(Figure 1A and 1B). The left eye showed only slight diffuse defects 
presumably due to early cataract formation. Retinoscopy revealed 
bilateral diffuse narrowing of the retinal arterioles (Figure 2A 
and 2B). In the right eye, changes suggested possible residual cot-
ton-wool spots within the large vascular arcade. The optic disks 
were flat and showed no evidence of papilledema. Haemorrhages 
were not observed.
Intravenous fluorescein angiography with digital measurements of 
systemic and retinal perfusion times was then performed in both 
eyes (Heidelberg Retina Angiograph). Videoangiography showed 
patchy filling of choroid in the right eye, which was not seen in 
left eye. The patient’s blood pressure was monitored during angi-
ography at 140/65 mmHg and her heart rate ranged between 84 
and 88 beats/min. A relatively short injection-to retina time was 
observed, which could be attributed to her heart rate (Table 1). The 
injection-to-retina time in the right eye was longer than in the left, 
perhaps consistent with the funduscopic differences.
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The patient was next referred to the Munich Hypertension 
Center for further cardiovascular analysis. The brachial blood 
pressure was 136/85 mmHg at the right arm and 137/82 mmHg 
at the left arm. Nonetheless, the pulse-wave analysis was abnor-
mal (Figure 3) showing an elevated central aortic blood pressure 
at the right arm with a systolic pressure 142.8 mmHg (normal for 
age <120 mmHg) [1] and an aortic augmentation index of 51.7% 
(normal for age <40%). The pulse-wave velocity was 11.8 m/s 
(normal for age <11 m/s). We subsequently initiated antihyper-
tensive medication with 5 mg amlodipine in the morning. Two 
months later, the pulse-wave analysis showed a brachial blood 
pressure of 135/83 mmHg, systolic central aortic blood pressure 
127.4 mmHg, aortic augmentation index 22.0% and pulse-wave 
velocity 8.8 m/s (Figure 4).
We repeated the ophthalmologic angiographic measurements after 
the masked central aortic hypertension was treated. The injection- 
to-retina time was increased by 12.5% in the right eye and by 16.6% 
Figure 1 | (A) and (B) Visual fields of right and left eye before therapy of 
aortic hypertension.
A B
Figure 2 | (A) and (B) Multicolor-image (Heidelberg Instruments Optical 
Coherence Tomography) of right and left eye posterior pole.
A B
Table 1 | Injection-retina-time (IRT), retinal-perfusion-time (RPT) and ratio of IRT/RPT before and after therapy of aortic hypertension
Normal
Right eye before and after therapy Left eye before and after therapy
Right eye before Right eye after Difference (%) Left eye before Left eye after Difference (%)
IRT 7–15 s 8.0 s 9.5 s +12.5 9.6 11.2 +16.6
RPT 6–10 s 8.0 s 8.3 s +4 6.9 6.8 −1.4
RPT–IRT-ratio 0.8–1.2 1.5 1.3 −13 1.08 0.91 −16
IRT, time difference between intravenous injection of fluorescein-bolus and first appearance of dye in the central retinal arteries reflecting the velocity of systemic circulation (brachial 
vein, heart, lung, carotid artery) mainly depending on heart rate; RPT, time difference between first appearance of dye within retinal arteries and complete filling of retinal venous vessels 
reflecting the capillary transit time of the fluorescein-bolus is regulated by retinal autoregulation; RPT–IRT-ratio, relation between systemic and retinal blood flow velocity.
in the left eye. Interestingly, the retinal perfusion time remained 
nearly the same in both eyes showing that the medical influence 
on systemic circulation did not have a negative effect on retinal 
circulation. The ratio between systemic and retinal circulation 
velocity, which was raised in right eye prior to therapy returned 
to near normal values with treatment (Table 1). Furthermore, the 
visual field defects that were present at the first evaluation were 
no longer detectable after treatment of the masked central aortic 
hypertension (Figure 5A and 5B).
3. DISCUSSION
Our patient developed severe hypertensive retinopathy on her right 
eye without hypertension as defined by conventional blood pressure 
measurement on the upper arm including ambulatory blood pressure 
monitoring over 24 h. However, pulse wave analysis revealed an ele-
vated central aortic blood pressure. Measuring blood pressure only at 
the brachial artery is no longer adequate in estimating cardiovascular 
health. Especially when hypertensive organ damage is present and 
brachial blood pressure is normal we need to assess central blood 
pressure. This important parameter remains masked when blood 
pressure is measured only at the brachial artery. However, available 
technology can unmask the situation and provides us with improved 
risk assessment. With aging and vascular risk factors, central vessels 
stiffened and the augmentation of systolic blood pressure becomes 
progressively greater. Pulse wave analysis is essential here. Simple 
noninvasive techniques are available for recording a high- fidelity 
waveform from an accessible pulse, permitting the estimate of an 
aortic or central waveform by application of a generalized transfer 
function. Determining pulse-wave velocity in meter per second is 
an important parameter of vascular elasticity and a predictor of car-
diovascular health [2]. An increase in reflected pulse wave due to 
increased velocity leads to a continuously increased systolic blood 
pressure augmentation. Augmentation designates the added systolic 
pressure contributed by the reflected pulse wave. As a result, the 
central aortic pressure progressively increases and is subsequently 
higher than the peripheral pressure at the brachial artery. The stiffer 
the vessels and the shorter the aorta as in short patients like little 
old ladies, the faster the pulse-wave velocity, and the greater is the 
augmentation effect on systolic central aortic blood pressure due to a 
faster and higher retrograde reflected wave.
The heart, kidneys, brain, and eye are more subject to central pres-
sures, compared with peripheral pressures. With increased vascu-
lar stiffness, the laminar flow component becomes progressively 
less and the pulsatile component increases. This pulsatile stress 
becomes progressively greater with advancing age. Particularly 
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Figure 5 | (A) and (B) Visual fields of 
right and left eye after therapy of aortic 
hypertension.
A B
Figure 3 | Original graph of 
arterial pulse wave measured 
with Arteriograph (Tensiomed, 
Budapest, Hungary) [3] before 
antihypertensive medication. 
Augmentation designates the 
added systolic pressure by the 
reflected pulse wave.
Figure 4 | Pulse-wave analysis 
under antihypertensive 
medication after 2 months. 
Systolic augmentation is 
supressed and Augmentation 
Index reduced from 51 to 22%.
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the afore- mentioned target organs are adversely affected and 
subjected to damage [4–7]. Little old ladies’ heart is described as 
diastolic heart failure as a consequence of increased arterial stiff-
ness, augmentation of central aortic pressure and increasing left 
ventricular tension and load [8]. Interestingly, in our patient the 
eye was the most important target organ. She had an increase in 
blind spots, detectable by visual field determinations. Moreover, 
her funduscopic picture was less healthy than her brachial artery 
blood pressure determinations or even ABPM results. Treating 
and decreasing central aortic blood pressure resolved the visual 
problem in our patient.
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